ENST00000637214.1:c.70-50761G>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000637214.1(GRIN2B):​c.70-50761G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 152,144 control chromosomes in the GnomAD database, including 42,091 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.74 ( 42091 hom., cov: 33)

Consequence

GRIN2B
ENST00000637214.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.10

Publications

6 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000637214.1 linkc.70-50761G>T intron_variant Intron 1 of 1 5 ENSP00000489997.1 A0A1B0GU78

Frequencies

GnomAD3 genomes
AF:
0.737
AC:
112018
AN:
152026
Hom.:
42051
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.584
Gnomad AMI
AF:
0.574
Gnomad AMR
AF:
0.798
Gnomad ASJ
AF:
0.776
Gnomad EAS
AF:
0.786
Gnomad SAS
AF:
0.785
Gnomad FIN
AF:
0.762
Gnomad MID
AF:
0.801
Gnomad NFE
AF:
0.803
Gnomad OTH
AF:
0.772
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.737
AC:
112110
AN:
152144
Hom.:
42091
Cov.:
33
AF XY:
0.739
AC XY:
54962
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.585
AC:
24235
AN:
41456
American (AMR)
AF:
0.799
AC:
12217
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.776
AC:
2696
AN:
3472
East Asian (EAS)
AF:
0.786
AC:
4069
AN:
5180
South Asian (SAS)
AF:
0.787
AC:
3795
AN:
4824
European-Finnish (FIN)
AF:
0.762
AC:
8069
AN:
10588
Middle Eastern (MID)
AF:
0.782
AC:
230
AN:
294
European-Non Finnish (NFE)
AF:
0.803
AC:
54640
AN:
68012
Other (OTH)
AF:
0.775
AC:
1637
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1443
2887
4330
5774
7217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
844
1688
2532
3376
4220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.785
Hom.:
83407
Bravo
AF:
0.731
Asia WGS
AF:
0.790
AC:
2745
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.059
DANN
Benign
0.20
PhyloP100
-1.1

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1457614; hg19: chr12-13641706; API